Possible HSP reactivation post‐COVID‐19 vaccination and booster

A 45‐year‐old woman with a history of Henoch‐Schönlein (HSP) purpura received COVID‐19 vaccination. The patient showed HSP reactivation after COVID‐19 vaccination and booster. In HSP, autoimmune memory of vasculitis persists and might be reactivated with COVID‐19 vaccination.

Detalles Bibliográficos
Autores principales: Kondo, Makoto, Yamanaka, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552090/
https://www.ncbi.nlm.nih.gov/pubmed/34745629
http://dx.doi.org/10.1002/ccr3.5032
_version_ 1784591309998129152
author Kondo, Makoto
Yamanaka, Keiichi
author_facet Kondo, Makoto
Yamanaka, Keiichi
author_sort Kondo, Makoto
collection PubMed
description A 45‐year‐old woman with a history of Henoch‐Schönlein (HSP) purpura received COVID‐19 vaccination. The patient showed HSP reactivation after COVID‐19 vaccination and booster. In HSP, autoimmune memory of vasculitis persists and might be reactivated with COVID‐19 vaccination.
format Online
Article
Text
id pubmed-8552090
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85520902021-11-04 Possible HSP reactivation post‐COVID‐19 vaccination and booster Kondo, Makoto Yamanaka, Keiichi Clin Case Rep Clinical Images A 45‐year‐old woman with a history of Henoch‐Schönlein (HSP) purpura received COVID‐19 vaccination. The patient showed HSP reactivation after COVID‐19 vaccination and booster. In HSP, autoimmune memory of vasculitis persists and might be reactivated with COVID‐19 vaccination. John Wiley and Sons Inc. 2021-10-28 /pmc/articles/PMC8552090/ /pubmed/34745629 http://dx.doi.org/10.1002/ccr3.5032 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Clinical Images
Kondo, Makoto
Yamanaka, Keiichi
Possible HSP reactivation post‐COVID‐19 vaccination and booster
title Possible HSP reactivation post‐COVID‐19 vaccination and booster
title_full Possible HSP reactivation post‐COVID‐19 vaccination and booster
title_fullStr Possible HSP reactivation post‐COVID‐19 vaccination and booster
title_full_unstemmed Possible HSP reactivation post‐COVID‐19 vaccination and booster
title_short Possible HSP reactivation post‐COVID‐19 vaccination and booster
title_sort possible hsp reactivation post‐covid‐19 vaccination and booster
topic Clinical Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552090/
https://www.ncbi.nlm.nih.gov/pubmed/34745629
http://dx.doi.org/10.1002/ccr3.5032
work_keys_str_mv AT kondomakoto possiblehspreactivationpostcovid19vaccinationandbooster
AT yamanakakeiichi possiblehspreactivationpostcovid19vaccinationandbooster

Ejemplares similares